Our finding are consistent with previous reports that have shown annexin A2 neutralizing antibodies to inhibit cell migration, invasion, and to block plasminogen activation of breast cancer cells [11] and monocytes [31] in vitro. This evidence concerns the gene ANXA2 and breast carcinoma.